Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNA‑damaging chemotherapy agents and radiation.

Duan Z, Andrews NP, Chen CZ, Fan M, Wang J, Shen J, Li JJ, Chen HW.

Oncol Rep. 2019 Nov 27. doi: 10.3892/or.2019.7418. [Epub ahead of print]

PMID:
31789405
2.

How Common Is Cyberbullying Among Adults? Exploring Gender, Ethnic, and Age Differences in the Prevalence of Cyberbullying.

Wang MJ, Yogeeswaran K, Andrews NP, Hawi DR, Sibley CG.

Cyberpsychol Behav Soc Netw. 2019 Nov;22(11):736-741. doi: 10.1089/cyber.2019.0146.

PMID:
31697598
3.

A toolbox of IgG subclass-switched recombinant monoclonal antibodies for enhanced multiplex immunolabeling of brain.

Andrews NP, Boeckman JX, Manning CF, Nguyen JT, Bechtold H, Dumitras C, Gong B, Nguyen K, van der List D, Murray KD, Engebrecht J, Trimmer JS.

Elife. 2019 Jan 22;8. pii: e43322. doi: 10.7554/eLife.43322.

4.

Maintenance of Genome Integrity by Mi2 Homologs CHD-3 and LET-418 in Caenorhabditis elegans.

Turcotte CA, Sloat SA, Rigothi JA, Rosenkranse E, Northrup AL, Andrews NP, Checchi PM.

Genetics. 2018 Mar;208(3):991-1007. doi: 10.1534/genetics.118.300686. Epub 2018 Jan 16.

6.

Is cardiac resynchronisation therapy feasible, safe and beneficial in the very elderly?

Olechowski B, Sands R, Zachariah D, Andrews NP, Balasubramaniam R, Sopher M, Paisey J, Kalra PR.

J Geriatr Cardiol. 2015 Sep;12(5):497-501. doi: 10.11909/j.issn.1671-5411.2015.05.003.

7.

Weekend admission and mortality from acute exacerbations of chronic obstructive pulmonary disease in winter.

Brims FJ, Asiimwe A, Andrews NP, Prytherch D, Higgins BR, Kilburn S, Chauhan AJ.

Clin Med (Lond). 2011 Aug;11(4):334-9.

8.

Routine laboratory tests can predict in-hospital mortality in acute exacerbations of COPD.

Asiimwe AC, Brims FJ, Andrews NP, Prytherch DR, Higgins BR, Kilburn SA, Chauhan AJ.

Lung. 2011 Jun;189(3):225-32. doi: 10.1007/s00408-011-9298-z. Epub 2011 May 10.

PMID:
21556787
9.

ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.

Kalashnikova EV, Revenko AS, Gemo AT, Andrews NP, Tepper CG, Zou JX, Cardiff RD, Borowsky AD, Chen HW.

Cancer Res. 2010 Nov 15;70(22):9402-12. doi: 10.1158/0008-5472.CAN-10-1199. Epub 2010 Sep 23.

11.

A nurse-led palpitations clinic: a 2-year experience.

Scott PA, Appleford P, Farrell TG, Andrews NP.

Postgrad Med J. 2010 Jan;86(1011):3-7. doi: 10.1136/pgmj.2008.071878.

PMID:
20065334
12.

Telomeres and immunological diseases of aging.

Andrews NP, Fujii H, Goronzy JJ, Weyand CM.

Gerontology. 2010;56(4):390-403. doi: 10.1159/000268620. Epub 2009 Dec 17. Review.

13.

Generation of antiviral major histocompatibility complex class I-restricted T cells in the absence of CD8 coreceptors.

Andrews NP, Pack CD, Lukacher AE.

J Virol. 2008 May;82(10):4697-705. doi: 10.1128/JVI.02698-07. Epub 2008 Mar 12.

14.

Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006).

Scott PA, Gorman S, Andrews NP, Roberts PR, Kalra PR.

Europace. 2008 Apr;10(4):453-7. doi: 10.1093/europace/eun042. Epub 2008 Mar 3.

PMID:
18319266
15.

Early virus-associated bystander events affect the fitness of the CD8 T cell response to persistent virus infection.

Andrews NP, Pack CD, Vezys V, Barber GN, Lukacher AE.

J Immunol. 2007 Jun 1;178(11):7267-75.

16.
17.

Regulation of antiviral CD8+ T cells by inhibitory natural killer cell receptors.

Byers AM, Kemball CC, Andrews NP, Lukacher AE.

Microbes Infect. 2003 Feb;5(2):169-77. Review.

PMID:
12650775
18.

Platelet inhibitory effect of nitric oxide in the human coronary circulation: impact of endothelial dysfunction.

Andrews NP, Husain M, Dakak N, Quyyumi AA.

J Am Coll Cardiol. 2001 Feb;37(2):510-6.

19.

N-acetylcysteine improves coronary and peripheral vascular function.

Andrews NP, Prasad A, Quyyumi AA.

J Am Coll Cardiol. 2001 Jan;37(1):117-23.

21.

Effect of systemic alpha-2 adrenergic blockade on the morning increase in platelet aggregation in normal subjects.

Andrews NP, Goldstein DS, Quyyumi AA.

Am J Cardiol. 1999 Aug 1;84(3):316-20.

PMID:
10496442
22.

Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability.

Prasad A, Andrews NP, Padder FA, Husain M, Quyyumi AA.

J Am Coll Cardiol. 1999 Aug;34(2):507-14.

23.

Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction.

Dakak N, Husain S, Mulcahy D, Andrews NP, Panza JA, Waclawiw M, Schenke W, Quyyumi AA.

Hypertension. 1998 Jul;32(1):9-15.

PMID:
9674631
24.

Aspirin improves endothelial dysfunction in atherosclerosis.

Husain S, Andrews NP, Mulcahy D, Panza JA, Quyyumi AA.

Circulation. 1998 Mar 3;97(8):716-20.

PMID:
9498533
25.

Blood pressure changes during transient myocardial ischemia: insights into mechanisms.

Rehman A, Zalos G, Andrews NP, Mulcahy D, Quyyumi AA.

J Am Coll Cardiol. 1997 Nov 1;30(5):1249-55.

26.

Nitric oxide activity in the atherosclerotic human coronary circulation.

Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO 3rd.

J Am Coll Cardiol. 1997 Feb;29(2):308-17.

27.

Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease.

Mulcahy D, Husain S, Zalos G, Rehman A, Andrews NP, Schenke WH, Geller NL, Quyyumi AA.

JAMA. 1997 Jan 22-29;277(4):318-24.

PMID:
9002495
28.

Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P.

Quyyumi AA, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO 3rd.

Circulation. 1997 Jan 7;95(1):104-10.

PMID:
8994424
29.

Mechanisms underlying the morning increase in platelet aggregation: a flow cytometry study.

Andrews NP, Gralnick HR, Merryman P, Vail M, Quyyumi AA.

J Am Coll Cardiol. 1996 Dec;28(7):1789-95.

30.

Patterns and behavior of transient myocardial ischemia in stable coronary disease are the same in both men and women: a comparative study.

Mulcahy D, Dakak N, Zalos G, Andrews NP, Proschan M, Waclawiw MA, Schenke WH, Quyyumi AA.

J Am Coll Cardiol. 1996 Jun;27(7):1629-36.

31.

Hepatitis B immunisation among invasive cardiologists: poor compliance with United Kingdom guidelines.

Prendergast BD, Andrews NP, Thomas A, Davies L, McCabe M, Penny WJ.

Br Heart J. 1995 Dec;74(6):685-8.

32.

Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.

Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO 3rd.

Circulation. 1995 Aug 1;92(3):320-6.

PMID:
7634444
33.

Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.

Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO 3rd.

J Clin Invest. 1995 Apr;95(4):1747-55.

34.

Spontaneous haemarthrosis following thrombolytic therapy for myocardial infarction.

Oldroyd KG, Hornung RS, Jones AM, Andrews NP, Dawes PT, Carson PH.

Postgrad Med J. 1990 May;66(775):387-8.

35.

Blood platelet behaviour in mothers and neonates.

Andrews NP, Broughton Pipkin F, Heptinstall S.

Thromb Haemost. 1985 Jun 24;53(3):428-32.

PMID:
3931289

Supplemental Content

Loading ...
Support Center